25.06.2024
Publications category: MIDD
25.06.2024
Optimal design of a reduced sampling schedule for the characterization of prolactin dynamics in healthy male volunteers and its evaluation to the describe the pharmacodynamic effect of a prolactin antagonist in a single rising dose study
25.06.2024
Model-informed early clinical development of BI-1808, a novel monoclonal antibody to tumor necrosis factor receptor 2
15.12.2023
Concentration-QTcF Analysis of Quizartinib in Patients With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)
15.12.2023
Population Pharmacokinetics (PopPK) of Quizartinib and Its Active Metabolite AC886 in Patients (Pts) With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)
25.10.2023
An item response theory model with bounded integer subcomponents to describe the Mayo Clinic subscores in patients with ulcerative colitis
16.10.2023
Writing reports of modelling and simulation analysis: Our experience in the field of pharmacometrics
10.10.2023
A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score
06.10.2023
Use of quantitative systems pharmacology pipelines to bridge in vitro and in vivo results in drug discovery
23.08.2023
Model Informed Drug Development: Collaboration Through A Common Framework
23.08.2023